Postoperative adjuvant EGFR-TKIs for resected EGFR-mutant NSCLC—opportunities and obstacles

Lignende værker

• Adjuvant EGFR TKIs in NSCLC harboring EGFR mutations: looking for a consensus way
  af: Attili, Ilaria, et al.
  Udgivet: (2020)
• Does TMB impact the effectiveness of TKIs in EGFR-mutant NSCLC?
  af: Cheng, Michael L., et al.
  Udgivet: (2018)
• The role of EGFR‐TKIs as adjuvant therapy in EGFR mutation‐positive early‐stage NSCLC: A meta‐analysis
  af: Lin, Chutong, et al.
  Udgivet: (2021)
• Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
  af: Wen, Miaomiao, et al.
  Udgivet: (2018)
• Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations
  af: Wei, Zhigang, et al.
  Udgivet: (2017)